I have helped multiple organizations communicate a wide array of events and milestones, from highly anticipated product launch roll-outs, to unexpected clinical results or shareholder actions. I bring a breadth and depth of experience to each client relationship, allowing me to address specific needs and projects from a holistic viewpoint to ensure my clients’ communications are well-informed and effective. My specific communications experience includes:
- R&D milestones (preclinical through registration)
- Regulatory actions (U.S. and EU)
- Product launches
- Commercial-stage, including DTC and physician education
- Corporate M&A
- Corporate development and licensing initiatives
- Crisis communications (product recalls, regulatory setbacks, partnership changes)
- Change management, including executive leadership
- Legal and SEC filings
- Employee and executive communications
- Exchange delisting
- Scientific communications and publications
- Shareholder events
My Background
Amy Trevvett, Principal
I have over 20 years of experience in life sciences communications, having served in various investor relations and corporate communications roles at publicly traded biotechnology, pharmaceutical and medical device companies. My life sciences communications experience spans preclinical through product commercialization, including development and regulatory milestones, product launches, M&A, crisis communications, and executive and employee communications.